Symptom dimensions, social network, and caregiver burden in chronic schizophrenia

Nordic Journal of Psychiatry

Volumn 54, Issue 2, 2000, Pages 121-125

  Taiminen, Tero ^a   Salokangas, Raimo K R ^a   Saarijärvi, Simo ^a   Syvälahti, Erkka ^a   Niemi, Heikki ^b   Ahola, Virpi ^a   Lehto, Heikki ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b H LUNDBECK A S   (Denmark)

Author keywords

Caregiver burden; Positive and negative syndrome scale; Schizophrenia; Social network

Indexed keywords

ADULT; ANXIETY; ARTICLE; CAREGIVER; DEPRESSION; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; OUTPATIENT; SCHIZOPHRENIA; SOCIAL ASPECT;

EID: 0034042863     PISSN: 08039488     EISSN: None     Source Type: Journal    
DOI: 10.1080/080394800427410     Document Type: Article

References (42)

1. Crow TJ. Molecular pathology of schizophrenia: more than one process? BMJ 1980;280:66-8.
2. Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 1987;151:145-51.
3. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia: methods, meanings, and mechanisms. Arch Gen Psychiatry 1995;52:341-51.
4. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry 1995;52:352-60.
5. Lindenmayer J-P, Bernstein-Hyman R, Grochowski S. Five-factor model of schizophrenia: initial validation. J Nerv Ment Dis 1994;182:631-8.
6. Lindenmayer J-P, Grochowski S, Hyman RB. Five factor model of schizophrenia: replication across samples. Schizophrenia Res 1995;14:229-34.
7. Salokangas RKR. Structure of schizophrenic symptomatology and its changes over time: prospective factor-analytical study. Acta Psychiatr Scand 1997;95:32-9.
8. Kay SR, Opler LA, Fiszbein A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
9. Lipton FR, Cohen CI, Fischer E, Katz SE. Schizophrenia: a network crisis. Schizophr Bull 1981;7:144-51.
10. Pattison EM, De Francisco D, Wood PE, Frazier H, Crowder JA. A psychosocial kinship model for family therapy. Am J Psychiatry 1975;132:1246-51.
11. Salokangas RKR. Living situation and social network in schizophrenia: a prospective 5-year follow-up study. Nord J Psychiatry 1996;50:35-42.
12. Salokangas RKR. Living situation, social network and outcome in schizophrenia: a five-year prospective follow-up study. Acta Psychiatr Scand 1997;96:459-68.
13. Marsella AJ, Snyder KK. Stress, social supports, and schizophrenic disorders: toward an interactional model. Schizophr Bull 1981;7:152-63.
14. Lam DH. Psychological family intervention in schizophrenia: a review of empirical studies. Psychol Med 1991;21:788-801.
15. Szmukler GI, Bloch S. Family involvement in the care of people with psychoses. Br J Psychiatry 1997;171:401-5.
16. Brown S, Birtwistle J. People with schizophrenia and their families: fifteen-year outcome. Br J Psychiatry 1998;173:139-44.
17. Provencher HL, Mueser KT. Positive and negative symptom behaviors and caregiver burden in the relatives of persons with schizophrenia. Schizophr Res 1997;26:71-80.
18. Gopinath PS, Chaturvedi SK. Distressing behaviour of schizophrenics at home. Acta Psychiatr Scand 1992;86:185-8.
19. Raj L, Kulkara P, Avasti A. Social burden of positive and negative symptom schizophrenia. Int J Soc Psychiatry 1991;37:242-50.
20. Runions J, Prudo R. Problem behaviors encountered by families living with a schizophrenic member. Can J Psychiatry 1983;28:382-6.
21. Webb C, Pfeiffer M, Mueser KT, Gladis M, Mensch E, DeGirolamo J, et al. Burden and well-being of caregivers for the severely mentally ill: the role of coping style and social support. Schizophr Res 1998;34:169-80.
22. Salokangas RKR, Saarijärvi S, Taiminen T, Kallioniemi H, Lehto H, Niemi H, et al. Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled study. Acta Psychiatr Scand 1996;94:175-80.
23. Taiminen TJ, Syvälahti E, Saarijärvi S, Niemi H, Lehto H, Ahola V, et al. Prediction of placebo response among chronic schizophrenic out-patients. J Nerv Ment Dis 1996;184:109-13.
24. Saarijärvi S, Taiminen T, Syvälahti E, Niemi H, Ahola V, Lehto H, et al. Relatives' participation in a clinical drug trial of schizophrenic outpatients improves their psychological well-being. Nord J Psychiatry 1998;52:389-93.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd rev ed., DSM-III-R. Washington (DC): The Association; 1987.
26. Schene AH, Van Wijngaarden B. Involvement Evaluation Questionnaire. Amsterdam: University of Amsterdam;1992.
27. Schene AH. Objective and subjective dimensions of family burden: towards an integrative framework for research. Soc Psychiatry Psychiatr Epidemiology 1990;25:289-97.
28. Schene AH, Tessler RC, Gamache GM. Instruments measuring family and caregiver burden in severe mental illness. Soc Psychiatry Psychiatr Epidemiol 1994;29:228-40.
29. Schene AH, van Wijngaarden B, Koeter MWJ. Family caregiving in schizophrenia: domains and distress. Schizophr Bull 1998;24:609-18.
30. Wyatt RJ. Biochemistry and schizophrenia. IV. The neuroleptics - their mechanism of action: a review of the biochemical literature. Psychopharmacol Bull 1976;12:5-55.
31. SAS Institute Inc. SAS statistical software, release 6.12. Cary (NC): SAS Institute Inc; 1996.
32. Taiminen T. Depression among schizophrenic patients - a selective review. Psychiatr Fenn 1994;25:185-94.
33. Scazufca M, Kuipers E. Stability of expressed emotion in relatives of those with schizophrenia and its relationship with burden of care and perception of patients' social functioning. Psychol Med 1998;28:453-61.
34. Taiminen TJ, Kujari H. Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients: a controlled retrospective study. Acta Psychiatr Scand 1994;90:247-51.
35. Magliano L, Fadden G, Fiorillo A, Malangone C, Sorrentino D, Robinson A, et al. Family burden and coping strategies in schizophrenia: are key relatives really different to other relatives? Acta Psychiatr Scand 1999;99:10-5.
36. Rose LE. Families of psychiatric patients: a critical review and future research directions. Arch Psychiatr Nursing 1996;10:67-76.
37. Vartiainen H, Tiihonen J, Putkonen A, Koponen H, Virkkunen M, Hakola P, et al. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatr Scand 1995;91:348-51.
38. Silver H, Nassar A. Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on, double-blind, placebo-controlled study. Biol Psychiatry 1992;31:698-704.
39. Spina E, De Domenico P, Ruello P, Longobardo N, Gitto C, Ancione M, et al. Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients. Int Clin Psychopharmacol 1994;9:281-5.
40. Kuipers E, Garety P, Fowler D, Dunn G, Bebbington P, Freeman D, et al. London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. Br J Psychiatry 1997;171:319-27.
41. Tarrier N, Yusupoff L, Kinney C, McCarthy E, Gledhill A, Haddock G, et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ 1998;317:303-7.
42. Macdonald EM, Pica S, McDonald S, Hayes RL, Baglioni AJ. Stress and coping in early psychosis: role of symptoms, self-efficacy, and social support in coping with stress. Br J Psychiatry 1998;172 Suppl 33:122-7.